Individual Tumor Profiling
Has Tumor Molecular Profiling Enabled More Effective and Less Toxic Cancer Treatment?
Top 10 Under 40
Up-and-Coming Stars Shine in Biopharma Research and Business
Podcast: FDA’s New Commissioner Hits the Ground Running
Scott Gottlieb, M.D., Commits to Speeding Up Drug Reviews, and Maintaining Safety and Efficacy
Liquid Biopsies Remain Wait and See for Some Clinicians
Circulating Biomarker Assays Promise to Refresh Cancer Profiling and Monitoring Practices
For full access to this article login to GEN Select now.
Using Nanotechnologies In Biotech and Medicine
Nanomaterials are More Than the Sum of Tiny Parts
- Of the 2004 global investment of $8.6 billion in nanotechnology, the earliest real payoffs may come from the biotechnology and pharmaceutical industries. Materials that exist in nanospace (generally defined as in the range of 100 nanometers to 0.1 nanometers) are not only smaller, but have entirely different physical ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.